Trial · NCT03040817
Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China
NCT03040817, Not applicable, Unknown, Zhongda Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China. Trials, record NCT03040817. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03040817
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China
- NCT number
- NCT03040817
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Zhongda Hospital
- Conditions
- Gastric Peroral Endoscopic Pyloromyotomy (G-POEM)
- Interventions
- Gastric peroral endoscopic pyloromyotomy (G-POEM), Esomeprazole + Mosapride
- First posted
- 2017-02-02
- Last updated
- 2017-08-29
Source ClinicalTrials.gov
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline in Gastric Emptying Imaging at 6 months. | From baseline to 6 months. | Each participant will receive gastric emptying imaging measurement both at baseline and 6 months. |
| Primary | Change from Baseline in Gastric Emptying Imaging at 12 months. | From baseline to 12 months. | Each participant will receive gastric emptying imaging measurement both at baseline and 12 months. |
| Primary | Change from Baseline in Gastric Emptying Imaging at 24 months. | From baseline to 24 months. | Each participant will receive gastric emptying imaging measurement both at baseline and 24 months. |
| Primary | Change from Baseline in Gastric Antrum Volume at 6 months. | From baseline to 6 months. | Each participant will receive gastric antrum volume measurement both at baseline and 6 months. |
| Primary | Change from Baseline in Gastric Antrum Volume at 12 months. | From baseline to 12 months. | Each participant will receive gastric antrum volume measurement both at baseline and 12 months. |
| Primary | Change from Baseline in Gastric Antrum Volume at 24 months. | From baseline to 24 months. | Each participant will receive gastric antrum volume measurement both at baseline and 24 months. |
| Primary | Change from Baseline in Gastric Emptying Time at 6 months. | From baseline to 6 months. | Each participant will receive gastric emptying time measurement both at baseline and 6 months. |
| Primary | Change from Baseline in Gastric Emptying Time at 12 months. | From baseline to 12 months. | Each participant will receive gastric emptying time measurement both at baseline and 12 months. |
| Primary | Change from Baseline in Gastric Emptying Time at 24 months. | From baseline to 24 months. | Each participant will receive gastric emptying time measurement both at baseline and 24 months. |
| Primary | Change from Baseline in Gastroparesis Cardinal Symptoms Index at 6 months. | From baseline to 6 months. | Each participant will receive gastroparesis cardinal symptoms index evaluation both at baseline and 6 months. |
1 to 10 of 15Source ClinicalTrials.gov
See all 15 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03040817
GET https://conductscience.org/api/trials/v1/NCT03040817/registered